Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - isoprenaline hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - isoprenaline hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - isoprenaline hydrochloride 0.2 mg/ml;  ; isoprenaline hydrochloride 200 µg/ml - solution for injection - 0.2 mg/ml - active: isoprenaline hydrochloride 0.2 mg/ml   excipient: lactic acid sodium chloride sodium lactate sodium metabisulfite water for injection active: isoprenaline hydrochloride 200 µg/ml excipient: citric acid disodium edetate hydrochloric acid nitrogen sodium chloride sodium citrate dihydrate sodium hydroxide water for injection - isuprel is indicated for: 1. mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. 2. serious episodes of heart block and adams-stokes attack (except when caused by ventricular tachycardia of fibrillation). 3. use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. 4. bronchospasm occurring during anaesthesia. 5. as an adjunct to fluid and electrolyte replacement therapy and the use of other medicines and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure, and cardiogenic shock.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kaken pharmaceutical co., ltd. - dl-isoprenaline hydrochloride - opaque white capsules (no.4 capsule)

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

kowa co., ltd. - dl-isoprenaline hydrochloride - white tablet, diameter: 7.2 mm, thickness: 4.2 mm

Ireland - English - HPRA (Health Products Regulatory Authority)

company liquidated m123 - isoprenaline hydrochloride - withdrawn form - 1 millilitre

Ireland - English - HPRA (Health Products Regulatory Authority)

company liquidated m123 - isoprenaline hydrochloride - withdrawn form - 5 millilitre

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hospira benelux bv-srl - isoprenaline hydrochloride 0,2 mg/ml - concentrate for solution for infusion - 0,2 mg/ml - isoprenaline hydrochloride 0.2 mg/ml - isoprenaline

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for injection - isoprenaline hydrochloride 0.2 mg/ml - cardiac therapy

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - solution for injection - isoprenaline hydrochloride 0.2 mg - cardiac therapy